These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 12519573

  • 1. Prevention of NSAID-induced gastroduodenal ulcers.
    Rostom A, Dube C, Wells G, Tugwell P, Welch V, Jolicoeur E, McGowan J.
    Cochrane Database Syst Rev; 2002; (4):CD002296. PubMed ID: 12519573
    [Abstract] [Full Text] [Related]

  • 2. Prevention of NSAID-induced gastroduodenal ulcers.
    Rostom A, Wells G, Tugwell P, Welch V, Dube C, McGowan J.
    Cochrane Database Syst Rev; 2000; (4):CD002296. PubMed ID: 11034748
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Prevention of NSAID induced gastroduodenal ulcers].
    Hansen JM, Bytzer P.
    Ugeskr Laeger; 2001 Oct 29; 163(44):6103-5. PubMed ID: 11715151
    [Abstract] [Full Text] [Related]

  • 5. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.
    Health Technol Assess; 2007 Dec 29; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
    Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C, Rostom A, Symmons D.
    Health Technol Assess; 2006 Oct 29; 10(38):iii-iv, xi-xiii, 1-183. PubMed ID: 17018227
    [Abstract] [Full Text] [Related]

  • 8. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M, Dezi A, Ferrario F, Capurso I.
    Arch Intern Med; 1996 Nov 11; 156(20):2321-32. PubMed ID: 8911239
    [Abstract] [Full Text] [Related]

  • 9. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ, Agrawal NM.
    Dig Dis; 1995 Jan 11; 13 Suppl 1():48-61. PubMed ID: 7697902
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials.
    Leandro G, Pilotto A, Franceschi M, Bertin T, Lichino E, Di Mario F.
    Dig Dis Sci; 2001 Sep 11; 46(9):1924-36. PubMed ID: 11575445
    [Abstract] [Full Text] [Related]

  • 12. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
    La Corte R, Caselli M, Castellino G, Bajocchi G, Trotta F.
    Drug Saf; 1999 Jun 11; 20(6):527-43. PubMed ID: 10392669
    [Abstract] [Full Text] [Related]

  • 13. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG.
    Am J Gastroenterol; 1996 Feb 11; 91(2):223-7. PubMed ID: 8607484
    [Abstract] [Full Text] [Related]

  • 14. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep 11; 20(119):216-9. PubMed ID: 21954519
    [Abstract] [Full Text] [Related]

  • 15. [What treatments can reduce the digestive complications of NSAIDs].
    Combe B, Flipo RM.
    Presse Med; 2003 Nov 22; 32(37 Pt 2):S33-7. PubMed ID: 14763352
    [Abstract] [Full Text] [Related]

  • 16. Proton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: a systematic review.
    Yang M, He M, Zhao M, Zou B, Liu J, Luo LM, Li QL, He JH, Lei PG.
    Curr Med Res Opin; 2017 Jun 22; 33(6):973-980. PubMed ID: 28076696
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Who needs prophylaxis of nonsteroidal anti-inflammatory drug-induced ulcers and what is optimal prophylaxis?
    Goldstein JL.
    Eur J Gastroenterol Hepatol; 2000 Jun 22; 12 Suppl 1():S11-5. PubMed ID: 10929893
    [Abstract] [Full Text] [Related]

  • 19. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens.
    Raskin JB, White RH, Jackson JE, Weaver AL, Tindall EA, Lies RB, Stanton DS.
    Ann Intern Med; 1995 Sep 01; 123(5):344-50. PubMed ID: 7625622
    [Abstract] [Full Text] [Related]

  • 20. Prevention of NSAID-induced gastroduodenal mucosal injury: meta-analysis of clinical trials with misoprostol and H2-receptor antagonists.
    Koch M, Capurso L, Dezi A, Ferrario F, Scarpignato C.
    Dig Dis; 1995 Jan 01; 13 Suppl 1():62-74. PubMed ID: 7697903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.